NASDAQ:ZIVO ZIVO Bioscience (ZIVO) Stock Price, News & Analysis → MarketBeat All Access New Year's Sale - Just $1.00 (From MarketBeat Internal) (Ad) Free ZIVO Stock Alerts $1.20 -0.10 (-7.69%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$1.20▼$1.7350-Day Range$0.49▼$16.3852-Week Range$0.48▼$22.50Volume2,128 shsAverage Volume11,490 shsMarket Capitalization$2.42 millionP/E RatioN/ADividend YieldN/APrice Target$36.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Ad MarketBeatMarketBeat All Access New Year's Sale - Just $1.00Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Save 75% Your 2024 Subscription. Just $1.00 for the first 30 days.Start Your Risk-Free Trial Here About ZIVO Bioscience Stock (NASDAQ:ZIVO)ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.Read More ZIVO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZIVO Stock News HeadlinesDecember 27, 2023 | americanbankingnews.comZIVO Bioscience (NASDAQ:ZIVO) Stock Price Crosses Below Fifty Day Moving Average of $1.97November 2, 2023 | msn.comZivo Bioscience (ZIVO) Price Target Increased by 500.00% to 36.72December 31, 2023 | MarketBeat Internal (Ad)Claim Your $300 MarketBeat Account CreditClick the link below to claim your $300.00 account credit toward MarketBeat All Access. Pay just $99.00 for your 2024 MarketBeat All Access subscription (normally $399.00)November 1, 2023 | morningstar.comZivo Bioscience Inc ZIVOOctober 30, 2023 | finance.yahoo.comZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensOctober 26, 2023 | markets.businessinsider.comZivo Bioscience Announces 1-for-6 Reverse Stock Split To Regain ComplianceOctober 26, 2023 | msn.comZivo Bioscience to effect reverse stock split to regain compliance with Nasdaq rulesOctober 3, 2023 | finance.yahoo.comZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceDecember 31, 2023 | MarketBeat Internal (Ad)New Year's Sale: Get MarketBeat All Access Free For 30 DaysAccess our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscriptionSeptember 19, 2023 | finance.yahoo.comTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensAugust 16, 2023 | businesswire.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife ™ Algal Biomass Product Produced Over the Next 18 MonthsAugust 16, 2023 | marketwatch.comZivo Bioscience: ZWorldwide to Buy All Zivolife Supply for First 18 Months of AgreementAugust 16, 2023 | finance.yahoo.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsJuly 26, 2023 | finance.yahoo.comZIVO Commences Sales of its Proprietary Algal Biomass as Human FoodJune 29, 2023 | marketwatch.comZivo Bioscience Shares Jump Premarket After Dropping Plans for Securities OfferingMay 30, 2023 | benzinga.comZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 30, 2023 | finance.yahoo.comZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 10, 2023 | investing.comSK Bioscience Co Ltd (302440)April 5, 2023 | msn.comZivo Bioscience gets $1M loan from CEOMarch 17, 2023 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Zivo Bioscience (ZIVO)February 10, 2023 | marketwatch.comZivo Bio Shares Slide 23% on High Mortality Rate in Coccidiosis Treatment StudyFebruary 10, 2023 | marketwatch.comStocks to Watch: Blue Apron, Zivo Bioscience, Berkshire GreyFebruary 10, 2023 | markets.businessinsider.comZIVO Reports Negative Results Of Study With Product Candidate For Coccidiosis Treatment In ChickensJanuary 29, 2023 | seekingalpha.comPressure BioSciences, One World team up to develop CBD sports performance drinksOctober 25, 2022 | finance.yahoo.comZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech BusinessSeptember 23, 2022 | finance.yahoo.comZIVO Bioscience CEO Issues Letter to ShareholdersSeptember 16, 2022 | finance.yahoo.comZIVO Bioscience, Inc. (ZIVO)See More Headlines Receive ZIVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/13/2023Today12/31/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/12/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ZIVO Previous SymbolOTCMKTS:HEPI CUSIPN/A CIK1101026 Webwww.zivobioscience.com Phone(248) 452-9866FaxN/AEmployees8Year FoundedN/APrice Target and Rating Average Stock Price Target$36.00 High Stock Price Target$36.00 Low Stock Price Target$36.00 Potential Upside/Downside+2,900.0%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,740,000.00 Net MarginsN/A Pretax Margin-53,021.81% Return on Equity-1,249.74% Return on Assets-561.44% Debt Debt-to-Equity RatioN/A Current Ratio0.61 Quick Ratio0.61 Sales & Book Value Annual Sales$20,000.00 Price / Sales121.20 Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-120.00Miscellaneous Outstanding Shares2,020,000Free Float1,748,000Market Cap$2.42 million OptionableNot Optionable Beta-0.07 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. John B. Payne (Age 75)President, CEO & Chairman of the Board Comp: $572.75kMr. Keith R. Marchiando (Age 61)CFO, Treasurer & Secretary Comp: $362.5kDr. Harlan L. Miller IIIVice President of Technology & Global SupplyKey CompetitorsTradeUP AcquisitionNASDAQ:UPTDBrickell BiotechNASDAQ:BBIEloxx PharmaceuticalsNASDAQ:ELOXPeak BioNASDAQ:PKBOAxcella HealthNASDAQ:AXLAView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 14,536 shares on 12/18/2023Ownership: 7.190%Armistice Capital LLCSold 222,000 shares on 11/15/2023Ownership: 46.084%Mark E StromeBought 40,000 shares on 6/2/2023Total: $199,600.00 ($4.99/share)View All Insider TransactionsView All Institutional Transactions ZIVO Stock Analysis - Frequently Asked Questions What is ZIVO Bioscience's stock price target for 2024? 0 equities research analysts have issued twelve-month price objectives for ZIVO Bioscience's stock. Their ZIVO share price targets range from $36.00 to $36.00. On average, they anticipate the company's stock price to reach $36.00 in the next year. This suggests a possible upside of 2,900.0% from the stock's current price. View analysts price targets for ZIVO or view top-rated stocks among Wall Street analysts. How have ZIVO shares performed in 2023? ZIVO Bioscience's stock was trading at $15.00 on January 1st, 2023. Since then, ZIVO stock has decreased by 92.0% and is now trading at $1.20. View the best growth stocks for 2023 here. When is ZIVO Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 12th 2024. View our ZIVO earnings forecast. How were ZIVO Bioscience's earnings last quarter? ZIVO Bioscience, Inc. (NASDAQ:ZIVO) posted its earnings results on Monday, November, 13th. The biotechnology company reported ($1.05) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $0.01 million for the quarter. When did ZIVO Bioscience's stock split? ZIVO Bioscience's stock reverse split on the morning of Friday, October 27th 2023. The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of ZIVO Bioscience? Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ZIVO) was last updated on 12/31/2023 by MarketBeat.com Staff From Our PartnersThe Quick Way To Tell If You Picked A Bad Trade…DTI TraderBuy This Stock for AI Tidal Wave (not NVDA)Chaikin Analytics LIVE DEMO: Elon Musk’s AI hits 65 MPHLegacy66,000% upside on tiny biotech?Behind the Markets AI Stock Caught Trading Under Secret NameThe Oxford Club1907, 1929, 1998, 2007--and now 2023?Stansberry ResearchTrading Champ Starting Over? TradewinsMaster the Market: Is That Stock Worth The Buy? Free Stock ReportVector Vest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.